China Biopharma Effects 1 for 100 Reverse S...(eir oldstock certificates for new stock ...)

Date:9/15/2008

eir old stock certificates for new stock certificates reflecting the adjusted number of shares as a result of the reverse stock split. Continental Stock Transfer & Trust Company, China Biopharma's transfer agent, will act as the exchange agent for purposes of implementing the exchange of stock certificates.

About China Biopharma, Inc.

China Biopharma Inc. is a biopharmaceutical company based in China. Through its operating subsidiaries, the company develops and distributes biopharmaceutical and pharmaceutical products throughout the world's most populated country, China. Products include human vaccines and other pharmaceutical drugs. Leveraging its local presence and the relationship with local Chinese bio-pharmaceutical companies and international biopharmaceutical companies, China Biopharma is building a highly-competitive platform for growth in China as well as new world markets, including the U.S. and Europe. For more information, visit its website at http://www.chinabiopharma.net.

Safe Harbor Statement

Some of the statements here discuss future events and developments, including the Company's future business strategy and its ability to generate revenue, income and cash flow, and should be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These "forward-looking" statements can generally be identified by words such as "expect," "anticipate," "believe," "estimate," "intend," "plan," and similar expressions. These statements involve a high degree of risk and uncertainty that exists in the Company's operations and business environment and are subject to change based on various factors that could cause actual Company results, performance, plans, goals and objectives to differ materially from those contemplated or implied in these forward-looking statements. Actual results may be different from anticipated results for a
'/>"/>

SOURCE China Biopharma, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. China Sky One Medical, Inc. Completes Acquisition of Peng Lai Jin Chuang Company
2. China Yingxia International, Inc. Appoints New Vice President of Finance
3. China-Biotics, Inc. Provides Update on Construction of New Manufacturing Facility
4. China Biologic Products to Present at the SIG Beijing Management Summit
5. China Biologics Production Facility Renews GMP Certification
6. China Bio Energy Holdings Group Announces Participation in the Susquehanna Second Annual Beijing Management Summit
7. Plexus Announces Expansion in Hangzhou, China
8. China Sky One Medical, Inc. Approved to List on the NASDAQ Global Market
9. China Pharma Holdings, Inc. Will Attend the Susquehanna Financial Group, LLP (SIG) Beijing Management Summit
10. ORBIS and Alcon Train Chinas Next Generation of Sight-Savers
11. China-Biotics, Inc. Continues to Broaden Bulk Additives Client Base